Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

NCT06447376 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin Lymphoma
Cytokine Release Syndrome

Interventions

DRUG: Siltuximab
DRUG: Epcoritamab

Sponsor

Taylor Brooks

Collaborators

[object Object]
[object Object]
[object Object]